A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models

A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models

The high prevalence and long latency period of prostate cancer (PCa) provide a unique opportunity to control disease progression with dietary and nutraceutical approaches. We developed ProFine, a standardized composition of luteolin, quercetin, and kaempferol, and investigated its potential as a nut...

Full description

Bibliographic Details
Main Authors:	Kenza Mamouni, Shumin Zhang, Xin Li, Yanhua Chen, Yang Yang, Jaeah Kim, Michael G. Bartlett, Ilsa M. Coleman, Peter S. Nelson, Omer Kucuk, Daqing Wu
Format:	Article
Language:	English
Published:	Elsevier 2018-08-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558618302653

Similar Items

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
by: W. Nathaniel Brennen, et al.
Published: (2021-04-01)

Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
by: Lina Gao, et al.
Published: (2013-01-01)

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
by: Katharina Lückerath, et al.
Published: (2018-10-01)

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
by: Lijuan Bai, et al.
Published: (2023-08-01)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
by: Christine Henzler, et al.
Published: (2016-11-01)

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.
by: Mark A Titus, et al.
Published: (2012-01-01)

Second generation androgen receptor antagonists and challenges in prostate cancer treatment
by: Yanhua Chen, et al.
Published: (2022-07-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
by: Choudhury Muhammad, et al.
Published: (2010-01-01)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
by: Aristomenis Anestis, et al.
Published: (2020-01-01)

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer
by: Jan Matthijs Moll, et al.
Published: (2022-06-01)

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
by: Won Sik Shin, et al.
Published: (2023-10-01)

α-Terthienyl induces prostate cancer cell death through inhibiting androgen receptor expression
by: Xia Gan, et al.
Published: (2022-08-01)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
by: Zoran Culig
Published: (2021-06-01)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
by: Kurtis Eisermann, et al.
Published: (2017-04-01)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
by: Lin Hui-Ping, et al.
Published: (2011-08-01)

Plasma Androgen Receptor in Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2019-11-01)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
by: Balaji Chandrasekaran, et al.
Published: (2023-03-01)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
by: Day Wanda V, et al.
Published: (2005-04-01)

Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids
by: Kenza Mamouni, et al.
Published: (2021-02-01)

Androgens and prostate disease
by: Lori A Cooper, et al.
Published: (2014-04-01)

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
by: Alfonso Urbanucci, et al.
Published: (2017-06-01)

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
by: Preston D. Crowell, et al.
Published: (2023-10-01)

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.
by: Jae-Kyung Myung, et al.
Published: (2017-01-01)

Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer
by: Nawel Mekdad, et al.
Published: (2022-10-01)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
by: Kah Ni Tan, et al.
Published: (2020-09-01)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
by: Simeng Wen, et al.
Published: (2020-07-01)

Androgens inhibit androgen receptor promoter activation in motor neurons
by: Guglielmo Vismara, et al.
Published: (2009-03-01)

Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells.
by: Matthew J Tanner, et al.
Published: (2011-01-01)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
by: Li Zhang, et al.
Published: (2016-01-01)

Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts
by: Patrick B. Thomas, et al.
Published: (2023-10-01)

Calcium Activation of the Androgen Receptor in Prostate Cells
by: Zeina W. Sharawi, et al.
Published: (2023-01-01)

Androgen Receptor-Mediated Transcription in Prostate Cancer
by: Doğancan Özturan, et al.
Published: (2022-03-01)

Splice variants of androgen receptor and prostate cancer
by: Orazio Caffo, et al.
Published: (2016-05-01)

Androgen receptor co-regulation in prostate cancer
by: Dhirodatta Senapati, et al.
Published: (2020-07-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study
by: Seierstad Therese, et al.
Published: (2011-06-01)

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells
by: Novelli Giuseppe, et al.
Published: (2007-06-01)

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer
by: Mariangela Calabrese, et al.
Published: (2023-12-01)

Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
by: James J. Hoy, et al.
Published: (2017-06-01)